[Left ventricular hypertrophy in patients with nephrogenic arterial hypertension]. 1994

A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia

Incidence and geometric peculiarities of hypertrophy of the left ventricle of the heart (HLVH) were studied on the basis of findings from the echocardiographic investigation done in 86 patients with chronic glomerulonephritis (ChGN) with arterial hypertension (AH), with the renal function being preserved and at the early stages of renal insufficiency. HLVH was detected in 30.2% of the patients, in 80.8% of whom it was concentric, and in 19.2% eccentric, in 76%--symmetric and in 23.1%--asymmetric. Incidence of HLVH did not correlate with sex, clinical variant of ChGN, renal function status, and increased with the degree and duration of AH. There was no difference in geometric peculiarities between sexes, clinical variants of ChGN, and no association with degree and duration of AH as well as with functional state of the kidneys.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
September 1985, Giornale italiano di cardiologia,
A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
February 1988, Presse medicale (Paris, France : 1983),
A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
November 1977, British heart journal,
A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
July 2002, Clinical nephrology,
A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
November 1995, Atencion primaria,
A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
October 2007, BMJ (Clinical research ed.),
A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
June 1984, La Revue de medecine interne,
A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
December 2006, Herzschrittmachertherapie & Elektrophysiologie,
A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
November 1991, Revista espanola de cardiologia,
A I Diadyk, and A E Bagriĭ, and A N Mitrofanov, and I A Lebed', and N F Iarovaia
October 1991, American heart journal,
Copied contents to your clipboard!